When people use sunscreen heavily, oxybenzone—a common ingredient—gets into the bloodstream more than other sunscreen chemicals, reaching levels more than 500 times higher than what the FDA considers worth checking for safety.
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
definitive
Can make definitive causal claims
Assessment Explanation
The claim is based on specific quantitative measurements from controlled human pharmacokinetic studies (e.g., FDA 2019 study), which directly measured plasma concentrations of sunscreen ingredients under standardized maximal use conditions. The use of 'geometric mean peak levels' and reference to the FDA threshold are precise and supported by empirical data. The claim does not overstate causation or mechanism—it reports observed concentrations relative to a regulatory benchmark. The verb 'reaches' is appropriately definitive given the direct measurement.
More Accurate Statement
“Under maximal use conditions, oxybenzone achieves the highest geometric mean peak plasma concentration among six tested sunscreen active ingredients, with levels exceeding 250 ng/mL in lotion formulations, which is substantially above the FDA’s 0.5 ng/mL safety screening threshold.”
Context Details
Domain
medicine
Population
human
Subject
oxybenzone
Action
reaches
Target
the highest plasma concentrations among six tested sunscreen active ingredients, exceeding 250 ng/mL in lotion formulations
Intervention Details
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Evidence from Studies
Supporting (1)
Effect of Sunscreen Application on Plasma Concentration of Sunscreen Active Ingredients: A Randomized Clinical Trial.